NCT00759421View on ClinicalTrials.gov

Exploratory Cognition Study of Sertindole in Patients With Schizophrenia

PHASE3CompletedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

March 31, 2008

Study Completion Date

April 30, 2008

Conditions
Schizophrenia
Interventions
DRUG

Sertindole

12 to 20 mg daily after initial up-titration, encapsulated tablets, orally, 84 days

DRUG

Olanzapine

10 to 20 mg daily after initial up-titration, encapsulated tablets, orally, 84 days

Trial Locations (1)

112

TWN001, Tapei

All Listed Sponsors
lead

H. Lundbeck A/S

INDUSTRY

NCT00759421 - Exploratory Cognition Study of Sertindole in Patients With Schizophrenia | Biotech Hunter | Biotech Hunter